BeiGene Files 2024 Annual Report Amendment
Ticker: BEIGF · Form: 10-K/A · Filed: Feb 28, 2025 · CIK: 1651308
| Field | Detail |
|---|---|
| Company | Beigene, LTD. (BEIGF) |
| Form Type | 10-K/A |
| Filed Date | Feb 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
BeiGene filed an amendment to its 2024 10-K, check for updates.
AI Summary
BeiGene, Ltd. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This filing, submitted on February 28, 2025, serves as an update to their previous submission. The company is registered in the Cayman Islands and operates in the Pharmaceutical Preparations industry.
Why It Matters
This amendment provides updated financial and operational information for investors and regulators, reflecting the company's performance and status as of the end of the 2024 fiscal year.
Risk Assessment
Risk Level: low — This filing is an amendment to a routine annual report and does not appear to contain new material adverse information.
Key Numbers
- 2024 — Fiscal Year End (The report covers the full fiscal year ending December 31, 2024.)
- 20250228 — Filing Date (This amendment was filed on February 28, 2025.)
Key Players & Entities
- BeiGene, Ltd. (company) — Registrant
- 2024 (date) — Fiscal year end
- February 28, 2025 (date) — Filing date
- Cayman Islands (location) — Jurisdiction of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific changes or additions are made in this Amendment No. 1 to the 10-K filing?
The filing indicates it is an 'Amendment No. 1' to the Annual Report, suggesting updates or corrections to the original filing, though the specific details of the changes are not provided in this header information.
What is the primary purpose of a 10-K/A filing?
A 10-K/A filing is an amendment to an annual report (Form 10-K) that allows a company to make corrections or add information to its previously filed report.
When was the original 10-K for the fiscal year ended December 31, 2024, likely filed?
Typically, a 10-K is filed within 60-90 days of the fiscal year end. Given this amendment was filed on February 28, 2025, the original filing would likely have been around late February or early March 2025.
What industry does BeiGene, Ltd. operate in?
BeiGene, Ltd. operates in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code 2834.
Where is BeiGene, Ltd. incorporated?
BeiGene, Ltd. is incorporated in the Cayman Islands.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on February 28, 2025 regarding BeiGene, Ltd. (BEIGF).